Hydroxychloroquine denied for missing prior authorization by Humana?

Humana's specific coverage criteria for hydroxychloroquine are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for Hydroxychloroquine — and How to Appeal a Denial

Humana routinely requires prior authorization (PA) for hydroxychloroquine (HCQ) to confirm that the diagnosis and intended use align with covered indications before the claim is paid. A denial at this stage does not mean HCQ is inappropriate for you — it means Humana's review determined the submitted information did not yet satisfy their authorization criteria. This is one of the most common and most successfully appealed denial types.

The most frequent reasons a PA denial occurs: the submitted clinical information was incomplete, the diagnosis code was vague or did not precisely match a covered indication, or the prescribing physician's office submitted the request without full supporting documentation.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 and ACA §2719, you have the right to a full-and-fair internal review. The denial letter must specify the timeframe, but you typically have at least 180 days from the denial date to file.
• External review: If the internal appeal is upheld, ACA §2719 entitles most plan members to independent external review by an IRO. You generally have four months (180 days) from the final adverse benefit determination to request external review.
• Expedited option: If your condition is urgent — for example, an active lupus flare — request simultaneous expedited internal and external review. Humana is required to respond within 72 hours on an expedited internal appeal.

## Documentation to Gather

1. Diagnosis confirmation — complete chart notes from your rheumatologist or treating physician, including the confirmed diagnosis (SLE, discoid lupus, or other FDA-labeled indication), disease activity documentation, and relevant lab or biopsy results. 2. Prescriber medical-necessity letter — a detailed letter explaining why HCQ is medically necessary for this patient, referencing the applicable specialty guideline organization (e.g., American College of Rheumatology) and the FDA-approved prescribing label. 3. Prior treatment history — a chronological list of other treatments tried, with start and end dates and clinical outcomes, particularly if HCQ is being used after other agents failed. 4. Humana's PA criteria — request the specific prior-authorization criteria from Humana's current drug coverage policy so your appeal can address each requirement point-by-point.

## Criteria-Mapping Structure

Organize your appeal letter so that each of Humana's stated PA criteria is listed, followed immediately by the specific chart evidence that satisfies it. For example: "Criterion: confirmed diagnosis of systemic lupus erythematosus — Met: rheumatology note dated [date] with ICD-10 code, ANA titer documented." This format prevents the reviewer from overlooking evidence and creates a clear record for any subsequent external review.